Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1031/week)
Manufacturing
(496/week)
Technology
(1022/week)
Energy
(412/week)
Other Manufacturing
(309/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
IgG4-related disease
Mar 04, 2020
CryoLife Receives CE Mark for E-vita Open NEO(TM) Hybrid Stent Graft
Dec 11, 2019
Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Nov 07, 2019
IgG4-Related Disease Epidemiology Forecast Report 2019-2028
Oct 01, 2019
Global IgG4-Related Disease Market Insights, Epidemiology, and Market Forecast to 2028
Sep 11, 2019
CryoLife Enters Into Distribution Agreement with Endospan
Aug 15, 2019
Global Aortic Stent Graft Market 2019-2024 - Opportunities in Growing Popularity of FEVAR, Strategic Mergers & Acquisitions, Emergence of EVAS
Aug 01, 2019
Market Leader for Patient Identification and Tracking Software, EonDirect, Expands to Abdominal Aortic Aneurysm
Mar 05, 2019
Nursing Mothers Can Now Get Care for Mastitis Quickly, Privately, and Without Leaving Home Using Bright.md's SmartExam(TM)
Jun 12, 2018
FDA Advisory Committee Votes in Favor of Cardinal Health's INCRAFT® AAA Stent Graft System for the Endovascular Treatment of Infrarenal Abdominal Aortic Aneurysms
Apr 27, 2018
Huiyihuiying and 301 Hospital jointly announce aortic AI research cloud platform AORTIST 2.0, aiming to make efficiency improvements to precise treatments
Dec 15, 2017
Northwestern Memorial Hospital Surgeon First in Illinois to Repair Damaged Aorta with "Frozen Elephant Trunk" Graft
Nov 07, 2017
Xencor Reports Third Quarter 2017 Financial Results and Provides Clinical Pipeline Update
Nov 06, 2017
CryoLife Announces Enrollment of First Patients in BioGlue® Clinical Trial in China
Nov 04, 2017
Xencor Presents Final Results from Phase 2 Study of XmAb®5871 in IgG4-Related Disease (IgG4-RD) at the American College of Rheumatology 2017 Annual Meeting
Oct 20, 2017
Xencor to Present Final Results from Phase 2 Study of XmAb®5871 in IgG4-Related Disease at American College of Rheumatology (ACR) 2017 Annual Meeting
Aug 07, 2017
Xencor Reports Second Quarter 2017 Financial Results
Jun 16, 2017
Xencor Presents Interim Data from an Ongoing, Open-label, Phase 2 Study of XmAb®5871 in IgG4-Related Disease at EULAR 2017
Latest News
Aug 28, 2025
USA Compression Partners, LP Announces Upsized Credit Facility
Aug 28, 2025
ATS to Participate in the Morgan Stanley 13th Annual Laguna Conference
Aug 28, 2025
Redwire to Present at Jefferies Industrials Conference on September 3, 2025
Aug 28, 2025
Fortive Declares Regular Quarterly Dividend on its Common Stock
Aug 28, 2025
American Water Appoints New Independent Member to the Board of Directors
Aug 28, 2025
Green Plains Enters into Agreement to Sell Obion, Tennessee Plant to POET
Aug 28, 2025
EnerSys Receives Refund of $137 Million Related to IRC Section 45X Tax Credits
Aug 28, 2025
Guess?, Inc. Reports Fiscal Year 2026 Second Quarter Results
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events